because this is all IP and early stage stuff. It may have a TAM of 400B but it takes decades to get products from pre-clinical to bedside. And there is no guarantee that any drug will take out any of addressable market. It is not as if it is to be valued at 400B.
- Forums
- ASX - By Stock
- IHL
- Ann: Incannex to Acquire APIRx Pharmaceuticals
Ann: Incannex to Acquire APIRx Pharmaceuticals, page-33
-
-
- There are more pages in this discussion • 428 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)